Evidence mapPaperPMID 40924150Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Synthesis, preclinical evaluation and clinical application of a novel heterodimeric tracer

Fan Jia, Dayong Hou, Han Zhang, Huihui You, Liang Cheng, Wei Liu, Yue Zhao, Xinyue Yang, Xinglu Zhou, Miao Yu and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Long-term performance evaluation of a novel 3.26 GBqEJNMMI radiopharmacy and chemistry · 2026
    Article
  2. αvβ3-targeted gas vesicles for ultrasound molecular imaging of tumors.Frontiers in bioengineering and biotechnology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fan Jia *Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Dayong Hou *Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China. houdayong@hrbmu.edu.cn.
Han Zhang *Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China.
Huihui YouDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Liang ChengDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Wei LiuDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Yue ZhaoDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Xinyue YangDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Xinglu ZhouDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Miao YuDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Geng HuDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Chenxu GuoDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Hongxue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Wanhai XuDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China. xuwanhai@hrbmu.edu.cn.
Kezheng WangDepartment of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China. wangkezheng9954001@163.com.ORCID 0000-0001-8776-5812

Funding

Distinguished Young Scientist Funding of Harbin Medical University Affiliated Tumor Hospital JCQN2019-02Harbin Medical University Cancer Hospital Haiyan Foundation JJYQ2024-03Heilongjiang Province unveiling and leading technology research and development project 2022ZXJ03C01Heilongjiang Provincial Natural Science Foundation of China PL2024H159Hong Kong Scholar Project XJ2024052Key Innovation Technology Project Harbin Medical University Cancer Hospital Innovation Technology Funding CXJSZD-2023-04Key Project of Harbin Medical University Cancer Hospital Climbing Funding PDYS2024-03National Key R&D Program of China 2021YFB3801000National Natural Science Foundation of China 82427806 and 82302266Provincial Key Research and Development Program of Heilongjiang Province GA21C001
6 · The paper itself

Abstract

objectiveCXCR4 and integrin α

methodsThe effects of

resultsIn vitro,

conclusion

Indexed as

Coordination ComplexesPeptides, CyclicPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAgedAnimalsCell Line, TumorFemaleGallium RadioisotopesHumansMaleMiceMice, Inbred BALB CMice, NudeMiddle AgedRadioactive Tracers68Ga-pentixaforCoordination ComplexesGallium RadioisotopesPeptides, CyclicRadioactive TracersRadiopharmaceuticalsBreast cancerCXCR4Integrin αvβ3Lung cancerProstate cancer

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.